Information

SCIENTIFIC RATIONALE
Nasopharyngeal Carcinoma (NPC) is a rare cancer in non-endemic settings. According to European Society of Medical Oncology (ESMO) guidelines, locally advanced disease is treated with combination of chemotherapy and radiotherapy. Recently, proton therapy has been introduced as a treatment option for nasopharyngeal carcinoma in light of its unique physical properties. However, late treatment sequelae still occur, and a small subset of patients experience disease relapse. In endemic setting, a new standard of care has been recently set with the introduction of immunotherapy in combination with platinum-based chemotherapy.
Almost all the evidence-based clinical indication in the management of this disease have been mutated from trials conducted in endemic areas. Therefore, there’s the urgent need to better refine the management of nasopharyngeal carcinoma in non-endemic setting.
This congress will provide the paramount opportunity to collect the expertise of internationally recognized physicians in the care of this disease and pave the way for knowledge building through the design of novel clinical trials conducted in non-endemic settings.

PROGRAM

Call for Abstract

We invite researchers, clinicians, and healthcare professionals to submit abstracts for the upcoming Congress.

This premier event will highlight the latest advancements in diagnosis, treatment, and translational research in nasopharyngeal carcinoma. Share your innovative findings, connect with global experts, and contribute to shaping the future of oncological care. Submit your abstract now and be part of the scientific dialogue driving progress in this critical field. The 6 best abstracts will be presented as Oral Presentation during the Congress.

ABSTRACT TOPICS
– Treatment strategies innovation in Nasopharyngeal Cancer
– Biomarkers in Nasopharyngeal Cancer
– Preclinical research in Nasopharyngeal Cancer
– Toxicity and Quality of Life in Nasopharyngeal Cancer

Abstract submission deadline: 31st October 2025

HOW TO SUBMIT YOUR ABSTRACT
To submit your abstract, please download the “Abstract Submission Form” HERE
Once your “Abstract Submission Form” is completed you can send it by clicking the following button.

SUBMIT YOUR ABSTRACT

Chairperson

Paolo Bossi Professor of Medical Oncology
Humanitas University,
Head of Head & Neck and
Non-melanoma Skin Cancer Oncology Unit,
Humanitas Research Hospital
Marta Scorsetti Resp. dell’Unità Operativa di Radioterapia e Radiochirurgia, Humanitas Research Hospital | Direttore Scuola di Specializzazione di Radioterapia, Humanitas University
Giuseppe Spriano Professor of Otolaryngology-Head & Neck Surgery,
Humanitas University,
Head of Department of Otolaryngology-Head & Neck Surgery,
Humanitas Research Hospital

Contact

ORGANIZING SECRETARIAT
Humanitas EDU
edu@hunimed.eu

Registration

Registration to the event is free and can be made at this web page only.

Maximum number of attendees: 150

SPECIALTIES INVOLVED
Otholaryngologist and ENT surgeons, Medical Oncologist, Radiation Oncologist, Anatomopathologist, Molecular Biologists, Radiologist and Nuclear Medicine specialist.